Preclinical Isolated Organ Perfusion System Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, China, India - Size and Forecast 2024-2028

Published: Oct 2023 Pages: 156 SKU: IRTNTR45363

Preclinical Isolated Organ Perfusion System Market 2024-2028

The Preclinical Isolated Organ Perfusion System Market size is estimated to grow by USD 137.63 million at a CAGR of 4.86% between 2023 and 2028. 

Key Findings:

  • The preclinical isolated organ perfusion system market remained historically at high levels from 2018 to 2023.
  • The market is segmented into End-user, Type, and Geography.
  • The industrial laboratories and CROs segment under the end-user category generated the largest revenue in 2018.
  • Key regions boosting the market growth include North America, Europe, Asia, and Rest of World (ROW).

Preclinical Isolated Organ Perfusion System Market Share

For More Highlights About this Report, Download Free Sample in a Minute 

Preclinical Isolated Organ Perfusion System Market: Key Drivers, Trends and Challenges

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Preclinical Isolated Organ Perfusion System Market Driver

One of the key factors driving the preclinical isolated organ perfusion system market growth is the increasing prevalence of chronic diseases. Isolated organ perfusion systems are extensively utilized in preclinical research to study organ-targeted delivery of drugs and the physiology and therapeutic interventions of drugs on isolated organs. The increasing prevalence of chronic conditions such as cancer, cardiovascular diseases, and respiratory diseases across the world is contributing to the market growth.

Moreover,  the rise in demand for new drugs will increase drug discovery activities, such as pharmacology and physiology studies, related to these diseases. As a result, there is an increasing adoption of isolated organ perfusion systems used to study the pharmacological effect of a new drug on isolated organs. Hence, such factors are expected to positively impact the market. Therefore, it is expected to drive market growth during the forecast period.

Key Preclinical Isolated Organ Perfusion System Market Trends

The growth of the preclinical isolated organ perfusion system market is driven by the increasing investment in research and development (R&D), particularly in preclinical research. Pharmaceutical companies are significant end-users of isolated organ perfusion systems, employing them as crucial tools in studying drug toxicity and evaluating the impact of new drug molecules on targeted organs.

Additionally, the growth in drug discovery and preclinical research activities is fueled by the rising R&D investments from key market players in the pharmaceutical industry. This, in turn, contributes significantly to the expansion of the preclinical isolated organ perfusion system market. The market is further propelled by the robust drug pipeline at various development stages, including the preclinical stage, coupled with ongoing R&D investments by companies, forecasting sustained growth throughout the forecast period.

Major Preclinical Isolated Organ Perfusion System Market Challenge

The elevated expense associated with isolated organ perfusion systems presents a significant obstacle to the growth of the preclinical isolated organ perfusion system market. The increasing demand for isolated organ studies, particularly in preclinical research, has driven the adoption of these systems. However, the high cost poses a notable challenge to market expansion. The pricing of isolated organ perfusion systems varies based on factors such as organ type, brand, and quality, typically falling within the range of USD30,000 to USD35,000.

Furthermore, the product's price fluctuates depending on domestic or international market rates, with variations linked to the specific organ under study. Certain organs may necessitate additional equipment for studying their specialized functions, such as a ventilator for isolated perfused lungs. Consequently, these factors impede market growth throughout the forecast period.

Preclinical Isolated Organ Perfusion System Market Segmentation

End-User Segment

The industrial laboratories and CROs segment is estimated to witness significant growth during the forecast period. This segment is one of the main organizations that are involved in drug discovery, research, design, and development. In addition, these organizations have the infrastructure required to conduct preclinical and clinical studies for testing various drug candidates. The rising investment of pharmaceutical companies in drug discovery and the increase in outsourcing activities to CROs is fuelling the growth of this segment.

Get a glance at the market contribution of various segments Download the PDF Sample

The industrial laboratories and CROs segment was the largest segment and was valued at USD 264.88 million in 2018.  Moreover, pharma and biotech companies are primarily involved in the discovery and development of drugs for a wide array of therapeutic applications. In addition, the increasing prevalence of chronic diseases, such as cardiovascular diseases and respiratory disorders, drives the demand for new drug discovery among these end-users. Furthermore, isolated organ perfusion systems are used to study the pharmacology of new drugs on isolated organs. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The North American preclinical isolated organ perfusion system market is poised for moderate growth due to factors like key vendor presence, technological advancements, increased funding in life science research, and the presence of established pharmaceutical companies and research institutes. Key vendors, including Harvard Bioscience Inc., Radnoti LLC, and emka TECHNOLOGIES, will drive market expansion. Adoption of advanced technologies, such as isolated organ perfusion systems, in preclinical research, especially in the US, a major revenue contributor, will further propel market growth.

In North America, the demand for laboratory equipment has increased with the presence of global and local pharmaceutical companies like Bristol-Myers Squibb, Merck and Co., Amgen Inc., Pfizer Inc., and Johnson and Johnson. These companies, focusing on R&D for new drug molecules, contribute to the rising demand for isolated organ perfusion systems used in pharmacological studies during preclinical research.Moreover, the market will be fueled by the increasing prevalence of chronic diseases and the demand for organ transplants. Isolated organ perfusion is crucial for developing organ preservation methods and studying organ viability before transplantation, aligning with the growing demand for organ transplantation in North America.

Key Companies in Preclinical Isolated Organ Perfusion System Market

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

ADInstruments Pty Ltd: The company offers preclinical isolated organ perfusion systems such as the Isolated Perfused Rodent Liver Foundation System which provides the glassware for perfusing an isolated rodent liver to maintain its hepatic function.

The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

  • ALA Scientific Instruments Inc.
  • emka TECHNOLOGIES
  • Harvard Bioscience Inc.
  • MDE GmbH
  • Radnoti LLC
  • World Precision Instruments
  • XVIVO Perfusion AB

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

 

Preclinical Isolated Organ Perfusion System Market Scope

Report Coverage

Details

Page number

156

Base year

2023

Historic period

 2018 - 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 4.86%

Market growth 2024-2028

USD 137.63 million

Market structure

Concentrated

YoY growth 2023-2024(%)

3.8

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 36%

Key countries

US, Canada, Germany, China, and India

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

ADInstruments Pty Ltd., ALA Scientific Instruments Inc., emka TECHNOLOGIES, Harvard Bioscience Inc., MDE GmbH, Radnoti LLC, World Precision Instruments, and XVIVO Perfusion AB

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download PDF Sample

What are the Key Data Covered in this Preclinical Isolated Organ Perfusion System Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2024 and 2028
  • Precise estimation of the size of the market  size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behaviour
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global preclinical isolated organ perfusion system market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global preclinical isolated organ perfusion system market 2018 - 2022 ($ million)
    • 4.2 End-user Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • 4.3 Type Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Industrial laboratories and CROs - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Industrial laboratories and CROs - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Industrial laboratories and CROs - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Industrial laboratories and CROs - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Industrial laboratories and CROs - Year-over-year growth 2023-2028 (%)
    • 6.4 Academic and government research institutes - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Academic and government research institutes - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Academic and government research institutes - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Academic and government research institutes - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Academic and government research institutes - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by End-user
      • Exhibit 42: Market opportunity by End-user ($ million)
      • Exhibit 43: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Exhibit 44: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on Type - Market share 2023-2028 (%)
    • 7.2 Comparison by Type
      • Exhibit 46: Chart on Comparison by Type
      • Exhibit 47: Data Table on Comparison by Type
    • 7.3 Isolated heart perfusion systems - Market size and forecast 2023-2028
      • Exhibit 48: Chart on Isolated heart perfusion systems - Market size and forecast 2023-2028 ($ million)
      • Exhibit 49: Data Table on Isolated heart perfusion systems - Market size and forecast 2023-2028 ($ million)
      • Exhibit 50: Chart on Isolated heart perfusion systems - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on Isolated heart perfusion systems - Year-over-year growth 2023-2028 (%)
    • 7.4 Isolated abdominal organ perfusion systems - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Isolated abdominal organ perfusion systems - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Isolated abdominal organ perfusion systems - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Isolated abdominal organ perfusion systems - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Isolated abdominal organ perfusion systems - Year-over-year growth 2023-2028 (%)
    • 7.5 Isolated lung perfusion systems - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Isolated lung perfusion systems - Market size and forecast 2023-2028 ($ million)
      • Exhibit 57: Data Table on Isolated lung perfusion systems - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Chart on Isolated lung perfusion systems - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Isolated lung perfusion systems - Year-over-year growth 2023-2028 (%)
    • 7.6 Cell isolation and others - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Cell isolation and others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 61: Data Table on Cell isolation and others - Market size and forecast 2023-2028 ($ million)
      • Exhibit 62: Chart on Cell isolation and others - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Cell isolation and others - Year-over-year growth 2023-2028 (%)
    • 7.7 Market opportunity by Type
      • Exhibit 64: Market opportunity by Type ($ million)
      • Exhibit 65: Data Table on Market opportunity by Type ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 China - Market size and forecast 2023-2028
      • Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.9 Germany - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.10 Canada - Market size and forecast 2023-2028
      • Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.11 India - Market size and forecast 2023-2028
      • Exhibit 103: Chart on India - Market size and forecast 2023-2028 ($ million)
      • Exhibit 104: Data Table on India - Market size and forecast 2023-2028 ($ million)
      • Exhibit 105: Chart on India - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on India - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ million)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 ADInstruments Pty Ltd.
              • Exhibit 115: ADInstruments Pty Ltd. - Overview
              • Exhibit 116: ADInstruments Pty Ltd. - Product / Service
              • Exhibit 117: ADInstruments Pty Ltd. - Key offerings
            • 12.4 ALA Scientific Instruments Inc.
              • Exhibit 118: ALA Scientific Instruments Inc. - Overview
              • Exhibit 119: ALA Scientific Instruments Inc. - Product / Service
              • Exhibit 120: ALA Scientific Instruments Inc. - Key offerings
            • 12.5 emka TECHNOLOGIES
              • Exhibit 121: emka TECHNOLOGIES - Overview
              • Exhibit 122: emka TECHNOLOGIES - Product / Service
              • Exhibit 123: emka TECHNOLOGIES - Key offerings
            • 12.6 Harvard Bioscience Inc.
              • Exhibit 124: Harvard Bioscience Inc. - Overview
              • Exhibit 125: Harvard Bioscience Inc. - Product / Service
              • Exhibit 126: Harvard Bioscience Inc. - Key offerings
            • 12.7 MDE GmbH
              • Exhibit 127: MDE GmbH - Overview
              • Exhibit 128: MDE GmbH - Product / Service
              • Exhibit 129: MDE GmbH - Key offerings
            • 12.8 Radnoti LLC
              • Exhibit 130: Radnoti LLC - Overview
              • Exhibit 131: Radnoti LLC - Product / Service
              • Exhibit 132: Radnoti LLC - Key offerings
            • 12.9 World Precision Instruments
              • Exhibit 133: World Precision Instruments - Overview
              • Exhibit 134: World Precision Instruments - Product / Service
              • Exhibit 135: World Precision Instruments - Key offerings
            • 12.10 XVIVO Perfusion AB
              • Exhibit 136: XVIVO Perfusion AB - Overview
              • Exhibit 137: XVIVO Perfusion AB - Business segments
              • Exhibit 138: XVIVO Perfusion AB - Key offerings
              • Exhibit 139: XVIVO Perfusion AB - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 140: Inclusions checklist
                • Exhibit 141: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 142: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 143: Research methodology
                • Exhibit 144: Validation techniques employed for market sizing
                • Exhibit 145: Information sources
              • 13.5 List of abbreviations
                • Exhibit 146: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              preclinical isolated organ perfusion system market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis